Your browser doesn't support javascript.
loading
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.
Schneider, Bryan P; Jiang, Guanglong; Ballinger, Tarah J; Shen, Fei; Chitambar, Christopher; Nanda, Rita; Falkson, Carla; Lynce, Filipa C; Gallagher, Christopher; Isaacs, Claudine; Blaya, Marcelo; Paplomata, Elisavet; Walling, Radhika; Daily, Karen; Mahtani, Reshma; Thompson, Michael A; Graham, Robert; Cooper, Maureen E; Pavlick, Dean C; Albacker, Lee A; Gregg, Jeffrey; Solzak, Jeffrey P; Chen, Yu-Hsiang; Bales, Casey L; Cantor, Erica; Hancock, Bradley A; Kassem, Nawal; Helft, Paul; O'Neil, Bert; Storniolo, Anna Maria V; Badve, Sunil; Miller, Kathy D; Radovich, Milan.
Afiliación
  • Schneider BP; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
  • Jiang G; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
  • Ballinger TJ; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
  • Shen F; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
  • Chitambar C; Medical College of Wisconsin, Milwaukee, WI.
  • Nanda R; University of Chicago, Chicago, IL.
  • Falkson C; University of Alabama at Birmingham, Birmingham, AL.
  • Lynce FC; Georgetown University, Washington, DC.
  • Gallagher C; Georgetown University, Washington, DC.
  • Isaacs C; Georgetown University, Washington, DC.
  • Blaya M; Memorial Healthcare System, Hollywood, FL.
  • Paplomata E; Winship Cancer Institute of Emory University, Atlanta, GA.
  • Walling R; Community Regional Cancer Care, Indianapolis, IN.
  • Daily K; University of Florida, Gainesville, FL.
  • Mahtani R; Sylvester Comprehensive Cancer Center, Deerfield Beach, FL.
  • Thompson MA; Advocate Aurora Health, Milwaukee, WI.
  • Graham R; Erlanger Health System, Chattanooga, TN.
  • Cooper ME; Foundation Medicine Inc, Cambridge, MA.
  • Pavlick DC; Foundation Medicine Inc, Cambridge, MA.
  • Albacker LA; Foundation Medicine Inc, Cambridge, MA.
  • Gregg J; Foundation Medicine Inc, Cambridge, MA.
  • Solzak JP; University of California at Davis, Sacramento, CA.
  • Chen YH; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
  • Bales CL; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
  • Cantor E; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
  • Hancock BA; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
  • Kassem N; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
  • Helft P; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
  • O'Neil B; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
  • Storniolo AMV; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
  • Badve S; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
  • Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
  • Radovich M; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
J Clin Oncol ; 40(4): 345-355, 2022 02 01.
Article en En | MEDLINE | ID: mdl-34910554
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Terapia Neoadyuvante / Medicina de Precisión / Neoplasias de la Mama Triple Negativas / Capecitabina / ADN Tumoral Circulante / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Terapia Neoadyuvante / Medicina de Precisión / Neoplasias de la Mama Triple Negativas / Capecitabina / ADN Tumoral Circulante / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Estados Unidos